Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy.

Hepatology (Baltimore, Md.) - 1 Aug 2005

Everson Gregory T, Trotter James, Forman Lisa, Kugelmas Marcelo, Halprin Arthur, Fey Barbara, Ray Catherine

Abstract excerpt

Patients with advanced hepatitis C virus (HCV) are at risk of death and are candidates for liver transplantation. After transplantation, HCV recurs and may rapidly progress to cirrhosis and graft loss. Treatment is needed to prevent progression of disease and minimize recurrence after liver transplantation. We evaluated the effectiveness, tolerability, and outcome of a low accelerating dose regimen (LADR) of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Liver Transplantation

Share to Recurrence

Share to Ribavirin

Source

Identifiers

PMID: 16025497
DOI: 10.1002/hep.20793

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy.PMID 16025497Read ↗

Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus.Semantic proximity Read ↗

Review article: the treatment of genotype 1 chronic hepatitis C virus infection in liver transplant candidates and recipients.Semantic proximity Read ↗

A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis c: pretreatment stratification by viral burden and genotype.Semantic proximity Read ↗

An escalating dose regimen of pegylated interferon and ribavirin in HCV cirrhotic patients referred for liver transplant.Semantic proximity Read ↗

Outcome of early vs. deferred antiviral treatment for recurrent hepatitis C in liver transplant recipients.Semantic proximity Read ↗

A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation.Semantic proximity Read ↗

High adherence with a low initial ribavirin dose in combination with pegylated-IFN alpha-2a for treatment of recurrent hepatitis C after liver transplantation.Semantic proximity Read ↗

Effect of scavenger receptor class B type I antagonist ITX5061 in patients with hepatitis C virus infection undergoing liver transplantation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.